Pull to refresh
Logo
Daily Brief
Following
Why Ranks Sign Up
JH

Jonathan Heeney

Scientific lead; founder of DIOSynVax

Appears in 1 story

Notable Quotes

"We've converted vaccine development from being reactive to being future-proof." — Jonathan Heeney

Stories

AI-designed universal coronavirus vaccine clears first human safety trial

New Capabilities

Leading the program into a planned Phase 2 trial

Vaccines have always chased the virus. You wait for a new strain, then design a shot to match it. A team at the University of Cambridge just tested a vaccine built the other way around: a machine-learning model designed its active ingredient to recognize a whole family of coronaviruses at once, including bat viruses that have never infected a person.

Updated Yesterday